Primary Biliary Cholangitis Clinical Trial Pipeline Pharmaceutical companies are advancing the Primary Biliary Cholangitis treatment pipeli ...

Bile duct disorders can lead to serious complications if left untreated, but early diagnosis and proper management can ...

Primary Biliary Cholangitis Clinical Trial Pipeline Pharmaceutical companies are advancing the Primary Biliary Cholangitis treatment pipeline to unlock future growth potential. LAS VEGAS, NV, UNITED S ...

In a recent study published in the Journal of Crohn’s and Colitis, researchers showed that oral vancomycin (OV) induces clinical remission in primary sclerosing cholangitis-associated inflammatory ...

The choice of antibiotics used to reduce the risk of cholangitis tends to be empirically ... Preprocedural fever despite empirical antibiotic treatment was documented in 40 examinations (10%).

GILD's strong HIV portfolio should maintain momentum for the company. The guidance for 2025 is impressive. We believe there ...

A common antibiotic prescribed for infective diarrhea may also be effective in treating a specific type of inflammatory bowel ...

Advanz Pharma's bid to keep its Ocaliva treatment for rare liver disease primary biliary cholangitis (PBC) on the EU market has ended in failure. The European Commission revoked the conditional ...

With Gilead Sciences' long-acting lenacapavir unlocking a reinvigorated focus on the pre-exposure prophylaxis (PrEP) market ...

A commonly used antibiotic called vancomycin, which is usually prescribed to treat infectious diarrhea, may also be helpful ...

F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have identified new benzimidazoles acting as serine/threonine-protein kinase SIK inhibitors reported to be useful for the treatment of rheumatoid ...